McKesson: Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity
McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity
Source link
McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long Opportunity
Source link
Ackman says he would short UnitedHealth, profitability ‘massively overstated' Source link
Tsakos Energy Navigation: A Compelling Purchase At Today's Price Source link
Udemy: Cheap Valuation Amid Enterprise AI-Upskilling Push Source link
Canadian retirees are searching for good dividend stocks to add to their self-directed Tax-Free Savings Account (TFSA) portfolios focused on generating reliable and growing passive income. This helps complement the Canada Pension Plan, Old Age Security, and company pensions. Despite the surge in the TSX over the past few months, investors can still get high…
Options trading strategies often rely on complex interactions between price movements, volatility dynamics, and time decay. Because these variables change constantly, traders and quantitative researchers depend heavily on historical data to understand how strategies would have performed under real market conditions. Backtesting provides a controlled environment where strategies can be evaluated before capital is deployed….
March S&P E-mini futures: The drop from 7043 probably ended at 6584 but if not then 6500 is the worst I see on the downside. In either case the upside target is 7500. QQQ: There is a good chance that the drop from 638 ended at 585. TNX (ten year note yield): The 3.75% level…